Gardner E M, Bernstein E D, Dran S, Munk G, Gross P, Abrutyn E, Murasko D M
Department of Microbiology and Immunology, MCP Hahnemann University School of Medicine, 2900 Queen Lane, Philadelphia, PA 19129, USA.
Vaccine. 2001 Sep 14;19(32):4610-7. doi: 10.1016/s0264-410x(01)00246-8.
The effects of yearly influenza immunization on the level of antibody responses were assessed in 92 healthy elderly subjects immunized over four contiguous years (1993-1996) with a trivalent influenza vaccine that included A/Texas annually. Anti-A/Texas antibodies increased significantly and similarly post-vaccination each year, but returned to comparable baseline levels annually. Percentages of subjects with anti-A/Texas titers > or =40 post-vaccination were comparable over four years. Importantly, post-vaccination titers > or =40 to A/Texas in 1993-1994 predicted anti-A/Texas titers > or =40 in subsequent years. Thirty percent of individuals produced four-fold rises to any vaccine component the first year it was included in the vaccine, however, this percentage decreased to about 10% after subsequent vaccination with the same component. This study clearly supports the concept that annual immunization with the same influenza vaccine component over multiple years does not significantly decrease antibody titers in a healthy elderly population.
在92名健康老年人中评估了连续四年(1993 - 1996年)每年接种流感疫苗对抗体反应水平的影响,这些老年人每年接种包含A/德州株的三价流感疫苗。每年接种疫苗后,抗A/德州株抗体显著且相似地增加,但每年又恢复到相当的基线水平。接种疫苗后抗A/德州株滴度≥40的受试者百分比在四年间相当。重要的是,1993 - 1994年接种疫苗后抗A/德州株滴度≥40可预测随后几年抗A/德州株滴度≥40。第一年疫苗中包含的任何疫苗成分有30%的个体产生四倍增长,但随后用相同成分再次接种疫苗后,这一百分比降至约10%。本研究明确支持这样的概念,即多年来每年用相同的流感疫苗成分进行免疫接种,在健康老年人群中不会显著降低抗体滴度。